Cargando…
Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates
BACKGROUND: Vancomycin‑resistant Staphylococcus aureus (VRSA) is a serious public health challenging concern worldwide. OBJECTIVES: Therefore, the objective of present study of 62 published studies was to evaluate the prevalence of VRSA based on different years, areas, isolate source, antimicrobial...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247230/ https://www.ncbi.nlm.nih.gov/pubmed/34193295 http://dx.doi.org/10.1186/s13756-021-00967-y |
_version_ | 1783716477492264960 |
---|---|
author | Wu, Qianxing Sabokroo, Niloofar Wang, Yujie Hashemian, Marzieh Karamollahi, Somayeh Kouhsari, Ebrahim |
author_facet | Wu, Qianxing Sabokroo, Niloofar Wang, Yujie Hashemian, Marzieh Karamollahi, Somayeh Kouhsari, Ebrahim |
author_sort | Wu, Qianxing |
collection | PubMed |
description | BACKGROUND: Vancomycin‑resistant Staphylococcus aureus (VRSA) is a serious public health challenging concern worldwide. OBJECTIVES: Therefore, the objective of present study of 62 published studies was to evaluate the prevalence of VRSA based on different years, areas, isolate source, antimicrobial susceptibility testing, and the genetic determinants. METHODS: We searched the relevant articles that focused on the prevalence rates of VRSA in PubMed, Scopus, Embase, and Web of Science from 2000 to 2019. Statistical analyses were conducted using STATA software (version 14.0). RESULTS: The prevalence of VRSA was 2% before 2006, 5% in 2006–2014, and 7% in 2015–2020 that showed a 3.5-fold increase in the frequency of VRSA between before 2006 and 2020 years. The prevalence of VRSA was 5% in Asia, 1% in Europe, 4% in America, 3% in South America, and 16% in Africa. The frequencies of VRSA isolated from clinical, non-clinical, and mixed samples were 6%, 7%, and 14%, respectively. The prevalence of VRSA was 12% using disk diffusion agar method, 7% using MIC-base methods, and 4% using mixed-methods. The prevalence of vanA, vanB, and vanC1 positive were 71%, 26%, and 4% among VRSA strains. The most prevalent genotype was staphylococcal cassette chromosomemec (SCCmec) II, which accounted for 57% of VRSA. The most prevalent staphylococcal protein A (spa) types were t002, t030, and t037. CONCLUSION: The prevalence of VRSA has been increasing in recent years particularly in Africa/Asia than Europe/America. The most prevalent of genetic determinants associated with VRSA were vanA and SCCmec II. This study clarifies that the rigorous monitoring of definite antibiotic policy, regular surveillance/control of nosocomial-associated infections and intensive surveillance of vancomycin-resistance are required for preventing emergence and further spreading of VRSA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-021-00967-y. |
format | Online Article Text |
id | pubmed-8247230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82472302021-07-06 Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates Wu, Qianxing Sabokroo, Niloofar Wang, Yujie Hashemian, Marzieh Karamollahi, Somayeh Kouhsari, Ebrahim Antimicrob Resist Infect Control Review BACKGROUND: Vancomycin‑resistant Staphylococcus aureus (VRSA) is a serious public health challenging concern worldwide. OBJECTIVES: Therefore, the objective of present study of 62 published studies was to evaluate the prevalence of VRSA based on different years, areas, isolate source, antimicrobial susceptibility testing, and the genetic determinants. METHODS: We searched the relevant articles that focused on the prevalence rates of VRSA in PubMed, Scopus, Embase, and Web of Science from 2000 to 2019. Statistical analyses were conducted using STATA software (version 14.0). RESULTS: The prevalence of VRSA was 2% before 2006, 5% in 2006–2014, and 7% in 2015–2020 that showed a 3.5-fold increase in the frequency of VRSA between before 2006 and 2020 years. The prevalence of VRSA was 5% in Asia, 1% in Europe, 4% in America, 3% in South America, and 16% in Africa. The frequencies of VRSA isolated from clinical, non-clinical, and mixed samples were 6%, 7%, and 14%, respectively. The prevalence of VRSA was 12% using disk diffusion agar method, 7% using MIC-base methods, and 4% using mixed-methods. The prevalence of vanA, vanB, and vanC1 positive were 71%, 26%, and 4% among VRSA strains. The most prevalent genotype was staphylococcal cassette chromosomemec (SCCmec) II, which accounted for 57% of VRSA. The most prevalent staphylococcal protein A (spa) types were t002, t030, and t037. CONCLUSION: The prevalence of VRSA has been increasing in recent years particularly in Africa/Asia than Europe/America. The most prevalent of genetic determinants associated with VRSA were vanA and SCCmec II. This study clarifies that the rigorous monitoring of definite antibiotic policy, regular surveillance/control of nosocomial-associated infections and intensive surveillance of vancomycin-resistance are required for preventing emergence and further spreading of VRSA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-021-00967-y. BioMed Central 2021-06-30 /pmc/articles/PMC8247230/ /pubmed/34193295 http://dx.doi.org/10.1186/s13756-021-00967-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Wu, Qianxing Sabokroo, Niloofar Wang, Yujie Hashemian, Marzieh Karamollahi, Somayeh Kouhsari, Ebrahim Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates |
title | Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates |
title_full | Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates |
title_fullStr | Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates |
title_full_unstemmed | Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates |
title_short | Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates |
title_sort | systematic review and meta-analysis of the epidemiology of vancomycin-resistance staphylococcus aureus isolates |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247230/ https://www.ncbi.nlm.nih.gov/pubmed/34193295 http://dx.doi.org/10.1186/s13756-021-00967-y |
work_keys_str_mv | AT wuqianxing systematicreviewandmetaanalysisoftheepidemiologyofvancomycinresistancestaphylococcusaureusisolates AT sabokrooniloofar systematicreviewandmetaanalysisoftheepidemiologyofvancomycinresistancestaphylococcusaureusisolates AT wangyujie systematicreviewandmetaanalysisoftheepidemiologyofvancomycinresistancestaphylococcusaureusisolates AT hashemianmarzieh systematicreviewandmetaanalysisoftheepidemiologyofvancomycinresistancestaphylococcusaureusisolates AT karamollahisomayeh systematicreviewandmetaanalysisoftheepidemiologyofvancomycinresistancestaphylococcusaureusisolates AT kouhsariebrahim systematicreviewandmetaanalysisoftheepidemiologyofvancomycinresistancestaphylococcusaureusisolates |